Squamous cell carcinoma of the skin classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 48: | Line 48: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |N2 | | style="background:#DCDCDC;" align="center" + |N2 | ||
| style="background:#F5F5F5;" align="left" + |* Metastasis in a single ipsilateral lymph node, tumor size ≤ 3 cm, and presence of extranodal extension; or | | style="background:#F5F5F5;" align="left" + | | ||
* Metastasis in a single ipsilateral lymph node, tumor size ≤ 3 cm, and presence of extranodal extension; or | |||
* Tumor size > 3 cm but ≤ 6 cm without extranodal extension; or | * Tumor size > 3 cm but ≤ 6 cm without extranodal extension; or | ||
* Metastasis in a single ipsilateral lymph node, tumor size ≤ 3 cm, and presence of extranodal extension; or | |||
* Metastases in multiple ipsilateral lymph nodes, tumor size ≤ 6 cm without extranodal extension; or | * Metastases in multiple ipsilateral lymph nodes, tumor size ≤ 6 cm without extranodal extension; or | ||
* In bilateral or contralateral lymph node(s), tumor size ≤ 6 cm without extranodal extension | * In bilateral or contralateral lymph node(s), tumor size ≤ 6 cm without extranodal extension | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |N2a | | style="background:#DCDCDC;" align="center" + |N2a | ||
| style="background:#F5F5F5;" align="left" + |Metastasis in a single ipsilateral lymph node 3 cm | | style="background:#F5F5F5;" align="left" + | | ||
* Metastasis in a single ipsilateral lymph node, tumor size ≤ 3 cm, and presence of extranodal involvement; or | |||
* Single ipsilateral node larger, tumor size > 3 cm and ≤ 6 cm, without extranodal extension | |||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |N2b | | style="background:#DCDCDC;" align="center" + |N2b | ||
| style="background:#F5F5F5;" align="left" + |Metastases in multiple ipsilateral nodes, | | style="background:#F5F5F5;" align="left" + |Metastases in multiple ipsilateral nodes, tumor size ≤ 6 cm, and without extranodal extension | ||
|- | |- | ||
| style="background:#DCDCDC;" align="left" + |N2c | | style="background:#DCDCDC;" align="left" + |N2c | ||
| style="background:#F5F5F5;" align="left" + |Metastases in bilateral or contralateral lymph node(s), | | style="background:#F5F5F5;" align="left" + |Metastases in bilateral or contralateral lymph node(s), tumor size ≤ 6 cm, and without extranodal extension | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |N3 | | style="background:#DCDCDC;" align="center" + |N3 | ||
| style="background:#F5F5F5;" align="left" + | Metastasis in a lymph node | | style="background:#F5F5F5;" align="left" + | | ||
In a single ipsilateral node | * Metastasis in a lymph node, tumor size > 6 cm, and without extranodal extension; or | ||
Multiple ipsilateral, contralateral, or bilateral nodes | * In a single ipsilateral node, tumor size > 3 cm, and presence of extranodal extension; or | ||
* Multiple ipsilateral, contralateral, or bilateral nodes with any extranodal exension; or | |||
* Single contralateral node of any size with any extranodal extension | |||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |N3a | | style="background:#DCDCDC;" align="center" + |N3a | ||
| style="background:#F5F5F5;" align="left" + |Metastasis in a lymph node | | style="background:#F5F5F5;" align="left" + |Metastasis in a lymph node, tumor size > 6 cm, and absence of extranodal extension | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |N3b | | style="background:#DCDCDC;" align="center" + |N3b | ||
| style="background:#F5F5F5;" align="left" + | Metastasis in a single ipsilateral node | | style="background:#F5F5F5;" align="left" + | | ||
Multiple ipsilateral, contralateral, or bilateral nodes, any | * Metastasis in a single ipsilateral node, tumor size > 3 cm, and in presence of extranodal extension; or | ||
* Multiple ipsilateral, contralateral, or bilateral nodes, with any extranodal extension; or | |||
* Single contralateral node of any size and with any extranodal extension | |||
|- | |- | ||
| colspan="2" style="background:#A9A9A9;" align="left" + |M - Distant metastasis | | colspan="2" style="background:#A9A9A9;" align="left" + |M - Distant metastasis | ||
|- | |- | ||
| style="background:#DCDCDC;" align="left" + |M0 | | style="background:#DCDCDC;" align="left" + |M0 | ||
Line 87: | Line 90: | ||
| style="background:#DCDCDC;" align="center" + |M1 | | style="background:#DCDCDC;" align="center" + |M1 | ||
| style="background:#F5F5F5;" align="left" + |Distant metastasis | | style="background:#F5F5F5;" align="left" + |Distant metastasis | ||
|} | |} | ||
Revision as of 00:03, 11 June 2019
Squamous cell carcinoma of the skin Microchapters |
Differentiating Squamous cell carcinoma of the skin from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Squamous cell carcinoma of the skin classification On the Web |
American Roentgen Ray Society Images of Squamous cell carcinoma of the skin classification |
Squamous cell carcinoma of the skin classification in the news |
Directions to Hospitals Treating Squamous cell carcinoma of the skin |
Risk calculators and risk factors for Squamous cell carcinoma of the skin classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2], Raviteja Guddeti, M.B.B.S. [3]
Overview
Classification
Category | Criteria |
---|---|
T - Primary tumor | |
TX | Primary tumor cannot be assessed |
Tis | Carcinoma in situ |
T1 | Tumor ≤ to 2 cm |
T2 | Tumor > 2 cm, and ≤ to 4 cm |
T3 | Tumor > 4 cm or minor bone erosion or perineural invasion or deep invasion |
T4 | Tumor with gross cortical bone/marrow, skull base invasion and/or skull base foramen invasion |
T4a | Tumor with gross cortical bone/marrow invasion |
T4b | Tumor with skull base invasion and/or skull base foramen involvement |
N - Regional lymph nodes | |
NX | Regional lymph nodes cannot be assessed |
N0 | No regional lymph node metastasis |
N1 | Metastasis in a single ipsilateral lymph node, tumor size ≤ 3 cm, and no extranodal extension |
N2 |
|
N2a |
|
N2b | Metastases in multiple ipsilateral nodes, tumor size ≤ 6 cm, and without extranodal extension |
N2c | Metastases in bilateral or contralateral lymph node(s), tumor size ≤ 6 cm, and without extranodal extension |
N3 |
|
N3a | Metastasis in a lymph node, tumor size > 6 cm, and absence of extranodal extension |
N3b |
|
M - Distant metastasis | |
M0 | No distant metastasis |
M1 | Distant metastasis |